Cadila scouts partners to ramp up Covid vaccine production by 50 to 70 mn
The Ahmedabad-based firm is looking to hire contract manufacturers for an additional 50 million to 70 million doses of its plasmid DNA vaccine27-10-2020
27-10-2020
Zydus Cadila's COVID vaccine to be ready by March; second vaccine in the works
Zydus Cadila's COVID-19 candidate vaccine ZyCov-D, which is currently undergoing second phase of clinical trials in India, is likely to enter Phase III final stage of clinical trials by December 202026-10-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Cadila Healthcare Limited - Q2 FY21 Post results Conference Call26-10-2020
Zydus Cadila gets USFDA nod for generic drug
Albuterol tablets are used to treat breathing problems23-10-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus Cadila receives final approval from USFDA for Albuterol Tablets23-10-2020
Cadila Healthcare Ltd - 532321 - Announcement under Regulation 30 (LODR)-Credit Rating
Credit Rating for commercial papers.22-10-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication21-10-2020
CADILA HEALTHCARE LTD. - 532321 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication21-10-2020
Cadila Healthcare Ltd - 532321 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter / Half Year Ended On September 30, 2020
CADILA HEALTHCARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2020 ,inter alia, to consider and approve approval of unaudited financial results for the quarter / half year ended on September 30, 202020-10-2020
Zydus Cadila gets USFDA nod for overactive bladder treatment drug
Drug firm Zydus Cadila on Tuesday said it has received final approval from the US health regulator to market Solifenacin Succinate tablets, used for treatment of overactive bladder20-10-2020